🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Stericycle shares target raised to $62 on Baird's FX, pricing review

EditorIsmeta Mujdragic
Published 07/23/2024, 01:05 PM
SRCL
-

On Tuesday, Baird maintained a Neutral rating on Stericycle (NASDAQ:SRCL) but raised the stock's price target from $55.00 to $62.00. The adjustment reflects updated evaluations of the company's performance, specifically considering second-quarter 2024 sorted office paper pricing and recent foreign exchange rate changes.

The firm's revised price target is founded on a valuation multiple of 12 times the enterprise value to estimated earnings before interest, taxes, depreciation, and amortization (EBITDA) for the year 2025. This new target aligns with the price offered by Waste Management (NYSE:WM) in its ongoing acquisition proposal for Stericycle.

Stericycle's stock adjustment comes in the wake of detailed financial assessments and market dynamics. The company, which specializes in regulated waste and compliance solutions, has been under scrutiny by investors as it navigates through the changing economic landscape marked by currency fluctuations and pricing shifts in its operational materials.

The updated price target by Baird suggests a tempered but optimistic outlook for Stericycle, indicating that the firm acknowledges potential growth or stability in the company's future financial performance. The Neutral rating implies that Baird advises investors to maintain their current positions in the stock, without a strong recommendation to buy or sell at this time.

Investors and market watchers will likely monitor Stericycle's stock performance, alongside the developments in the Waste Management acquisition bid, to gauge the company's trajectory in the coming months. The revised price target offers a numerical benchmark for evaluating Stericycle's market value as it progresses through the second half of 2024.

In other recent news, Stericycle has been in the spotlight due to significant financial developments and strategic moves. The company reported an increase in adjusted earnings per share and adjusted EBITDA in Q1 2024, despite a decrease in revenue. This financial growth was accompanied by the launch of the Shred-it ProtectPLUS service, aimed at enhancing customer retention and cash flow.

In a significant development, Waste Management announced its intention to acquire Stericycle, with a proposal valued at approximately $7 billion. This acquisition, which corresponds to a per-share price near $61, is expected to be finalized by the fourth quarter of 2024, with an option to extend the closing deadline until June 3, 2026.

The deal's estimated value suggests an acquisition multiple of approximately 14.8 times the forecasted pre-synergy earnings before interest, taxes, depreciation, and amortization (EBITDA) for the fiscal year 2024.

Amidst these developments, Stifel maintained a Hold rating on Stericycle stock with a consistent price target of $62.00, and later reiterated its Buy rating. The Stifel analyst also removed Stericycle from the Stifel Select List in light of the acquisition agreement.

These are recent developments that investors are closely monitoring.

InvestingPro Insights

As Stericycle (NASDAQ:SRCL) finds itself at a pivotal moment, insights from InvestingPro shed additional light on the company's financial health and market position. Notably, Stericycle's net income is expected to grow this year, aligning with Baird's revised price target and reflecting a potential turnaround from its non-profitable status over the last twelve months. Moreover, the company's strong return over the last three months, with a 16.55% price total return, underscores a robust short-term performance that investors may find encouraging.

On the valuation front, Stericycle's P/E ratio stands at a high 67.54, suggesting a premium market expectation of future earnings growth. Additionally, the stock is trading near its 52-week high, at 98.67% of the peak, which could signal confidence among investors or, conversely, a cautious sign for those wary of buying at the top.

For those looking for a deeper dive into Stericycle's prospects, InvestingPro offers several additional InvestingPro Tips. Utilize coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, and access a full suite of analytics and expert insights to navigate your investment decisions with precision.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.